For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Transcriptomics incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomics market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomics solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Scope of the Report:
This report studies the Transcriptomics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transcriptomics market by product type and applications/end industries.
The international transcriptomics market is expected to gain impetus from the increasing amount of investments directed toward research and development activities in molecular genetics. Newer innovations such as those pertaining to next-generation sequencing (NGS) and RNA interference (RNAi) have birthed as a result of the technological advancements in the international transcriptomics market. With improved precision and accuracy, these cutting-edge technologies can be put to use with a view to help researchers analyze the transcriptional activity of a vast range of diverse organisms. This will in turn assist to furnish precise outcomes and manage colossal quantities of transcriptomics data with the help of improved data analysis practices.
High cost of service on account of the dearth of trained professionals and high input cost is projected to discourage end users from opting for transcriptomics. Howbeit, cheaper and novel technologies that keep cost in view are anticipated to set the tone for the global transcriptomics market. The analysts foresee a steady growth over the forecast years on the part of the global transcriptomics market as cardiac diseases coupled with pollution-related ailments spread their presence worldwide. Biotechnology research and drug innovation actively and extensively employ transcriptomics technologies.
The global Transcriptomics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transcriptomics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- QIAGEN (Exiqon)
- Thermo Fisher Scientific
- Agilent Technologies
- GE Healthcare Dharmacon
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Fluidigm Corporation
- Promega Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Real Time-PCR (qPCR)
Market Segment by Applications, can be divided into
- Government Institutes & Academic Centers
- Pharmaceutical & Biotechnology Companies
- Contract research Organizations (CROs)